Merck COVID-19 pill molnupiravir, which has been found to reduce the risk of hospitalisation, has been cleared for use in U.K. – its first authorisation, with authorisation in the U.S. expected soon to follow.
Merck COVID-19 pill molnupiravir, which has been found to reduce the risk of hospitalisation, has been cleared for use in U.K. – its first authorisation, with authorisation in the U.S. expected soon to follow.